The use of monotherapy with angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), thiazides, and calcium channel blockers (CCBs), as well as combination treatment for individuals with stage 2 HTN, has been recommended [20,23,24,28]. This evidence concerns the gene ACE and hypertensive disorder.